Table 5.
Blood components of the CT-scanned samples after a period of 8 weeks
| Control | 4 weeks after the last scan (8 weeks) | p | |
|---|---|---|---|
| (a) Male (n = 5) | |||
| RBC (104/μL) | 1035.80 ± 72.68 | 1068.80 ± 85.91 | 0.07 |
| HGB (g/dL) | 16.82 ± 1.36 | 17.08 ± 1.32 | 0.21 |
| HCT (%) | 51.20 ± 3.35 | 51.94 ± 4.60 | 0.06 |
| MCV (fL) | 49.46 ± 1.29 | 48.56 ± 0.75 | 0.14 |
| MCH (pg) | 22.24 ± 13.53 | 16.00 ± 0.25 | 0.08 |
| MCHC (g/dL) | 32.84 ± 0.94 | 32.92 ± 0.51 | 0.27 |
| PLT (104/μL) | 147.48 ± 14.19 | 138.96 ± 13.75 | 0.06 |
| WBC (102/μL) | 61.52 ± 18.82 | 66.44 ± 17.00 | 0.34 |
| LYMPH (%) | 73.38 ± 11.16 | 78.12 ± 5.62 | 0.44 |
| NEUT (%) | 18.40 ± 8.29 | 14.70 ± 5.40 | 0.07 |
| EO (%) | 2.40 ± 1.82 | 2.10 ± 0.91 | 0.11 |
| BASO (%) | 0.06 ± 0.09 | 0.02 ± 0.04 | 0.15 |
| MONO (%) | 5.76 ± 2.85 | 5.06 ± 0.64 | 0.12 |
| (b) Female (n = 5) | |||
| RBC (104/μL) | 1047.00 ± 76.73 | 986.75 ± 9.18 | 0.49 |
| HGB (g/dL) | 16.42 ± 1.56 | 15.73 ± 0.40 | 0.21 |
| HCT (%) | 50.04 ± 3.05 | 48.45 ± 0.51 | 0.30 |
| MCV (fL) | 47.76 ± 1.30 | 41.58 ± 15.00 | 0.26 |
| MCH (pg) | 15.68 ± 0.56 | 45.93 ± 60.25 | 0.09 |
| MCHC (g/dL) | 32.80 ± 1.36 | 32.45 ± 0.66 | 0.16 |
| PLT (104/μL) | 107.72 ± 25.88 | 109.63 ± 20.52 | 0.09 |
| WBC (102/μL) | 47.94 ± 15.91 | 48.75 ± 14.69 | 0.23 |
| LYMPH (%) | 81.42 ± 0.76 | 80.48 ± 1.33 | 0.10 |
| NEUT (%) | 13.30 ± 1.85 | 12.25 ± 1.41 | 0.33 |
| EO (%) | 1.78 ± 1.00 | 3.43 ± 1.88 | 0.49 |
| BASO (%) | 0.01 ± 0.01 | 0.01 ± 0.01 | 0.37 |
| MONO (%) | 3.50 ± 1.46 | 3.85 ± 2.33 | 0.28 |
There were no significant differences between the mean values